Trials / Completed
CompletedNCT03833050
The TOGETHER Project - Heart
The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Heart Transplant Recipients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
Detailed description
The study will utilize peripheral blood assays collected at time points that are considered standard of care at most institutions. Subjects will have peripheral blood collected at 1 month, 3 months, 6 months, and 12 months after heart transplantation, as well as any for cause time points. These samples will then be used for purposes of developing an RNA-seq based peripheral blood assay in adult heart transplant recipients.
Conditions
Timeline
- Start date
- 2017-12-07
- Primary completion
- 2020-09-22
- Completion
- 2020-09-22
- First posted
- 2019-02-06
- Last updated
- 2022-06-14
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03833050. Inclusion in this directory is not an endorsement.